Effect of Increased Free Fatty Acid Supply on Glucose Metabolism and Skeletal Muscle Glycogen Synthase Activity in Normal Man
Overview
General Medicine
Science
Affiliations
1. Experimental elevation of plasma non-esterified fatty acid concentrations has been postulated to decrease insulin-stimulated glucose oxidation and storage rates. Possible mechanisms were examined by measuring skeletal muscle glycogen synthase activity and muscle glycogen content before and during hyperinsulinaemia while fasting plasma non-esterified fatty acid levels were maintained. 2. Fasting plasma non-esterified fatty acid levels were maintained in seven healthy male subjects by infusion of 20% (w/v) Intralipid (1 ml/min) for 120 min before and during a 240 min hyperinsulinaemic euglycaemic clamp (100 m-units h-1 kg-1) combined with indirect calorimetry. On the control day, 0.154 mol/l NaCl was infused. Vastus lateralis muscle biopsy was performed before and at the end of the insulin infusion. 3. On the Intralipid study day serum triacylglycerol (2.24 +/- 0.20 versus 0.67 +/- 0.10 mmol/l), plasma nonesterified fatty acid (395 +/- 13 versus 51 +/- 1 mumol/l), blood glycerol (152 +/- 2 versus 11 +/- 1 mumol/l) and blood 3-hydroxybutyrate clamp levels [mean (95% confidence interval)] [81 (64-104) versus 4 (3-5) mumol/l] were all significantly higher (all P less than 0.001) than on the control study day. Lipid oxidation rates were also elevated (1.07 +/- 0.07 versus 0.27 +/- 0.08 mg min-1 kg-1, P less than 0.001). During the clamp with Intralipid infusion, insulin-stimulated whole-body glucose disposal decreased by 28% (from 8.53 +/- 0.77 to 6.17 +/- 0.71 mg min-1 kg-1, P less than 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)
Aging delays the suppression of lipolysis and fatty acid oxidation in the postprandial period.
Osmond A, Leija R, Arevalo J, Curl C, Duong J, Huie M J Appl Physiol (1985). 2024; 137(5):1200-1219.
PMID: 39236144 PMC: 11563596. DOI: 10.1152/japplphysiol.00437.2024.
DNA methylation in the pathogenesis of type 2 diabetes in humans.
Davegardh C, Garcia-Calzon S, Bacos K, Ling C Mol Metab. 2018; 14:12-25.
PMID: 29496428 PMC: 6034041. DOI: 10.1016/j.molmet.2018.01.022.
Foundations of Immunometabolism and Implications for Metabolic Health and Disease.
Hotamisligil G Immunity. 2017; 47(3):406-420.
PMID: 28930657 PMC: 5627521. DOI: 10.1016/j.immuni.2017.08.009.
Glycogen metabolism in humans.
Adeva-Andany M, Gonzalez-Lucan M, Donapetry-Garcia C, Fernandez-Fernandez C, Ameneiros-Rodriguez E BBA Clin. 2016; 5:85-100.
PMID: 27051594 PMC: 4802397. DOI: 10.1016/j.bbacli.2016.02.001.
Constantinou C, Apidianakis Y, Psychogios N, Righi V, Mindrinos M, Khan N Int J Mol Med. 2015; 37(2):299-308.
PMID: 26648055 PMC: 4716799. DOI: 10.3892/ijmm.2015.2426.